Inbody: An intelligent device from Biospace

With the continuing increase in standard of living, the focus on quality of life has am­plified in recent times. In particular, obesity is a health issue featured in the mass media that has been warranting more attention than ever before. More and more people are coming to realise that obesity is at the root of all habitual illnesses, and because of this correlation interest in obesity treatment is on the rise.

Biospace’s body composition analyser, InBody stands at the centre of this anti-obesity movement. With ‘InBody’ which is operated by an exclusive technology, Biospace is a total-healthcare enterprise that ranks first in Korean body composition analyser market and second in body composition analyser market for experts.

Up until recently, most people believed that obesity could be precluded by simply losing a certain number of kilograms in body weight. However, with the development of the InBody, Biospace has made the terms, “body composition” and “body fat,” popular and has spread the knowledge that the prevention of obesity hinges on the reduction and control of body fat.

As a main product of Biospace, InBody analyses body composition by measuring bio impedance that is created when passing minute currents in human body. InBody measures muscle mass, body fat mass, total body water, protein and mineral with a basic principle that currents tend to go through muscles well and not fat (due to the different amount of body water). Biospace’s trailblazing activities in this area are evi­dent in the label of “InBody test”, a commonly given body composition analysis that has recently increased in popularity.

Body composition analyzers have existed for many years, but Biospace developed ‘Direct Segmental Measuring Method’, reportedly first in the world, improving accuracy and reproducibility. InBody is the world’s first body composition analysis device that uses the 8-point tactile electrode method. Having received FDA approval in the United States and approval of other countries’ authorities, such as in Japan, this product’s high quality and accuracy has been validated.

With the unparalleled performance of the InBody in the domestic obesity diagnosis market Biospace has solidified its foundation as a professional medical device manu­facturer. With its accuracy, high reproducibility rate and fast simple measurement method, InBody is being used to measure basic health conditions in over 20,000 hospitals and sports centres in Korea.

The plan for the future entails the company’s ongoing development and expansion into a comprehensive professional healthcare organisation. After the success in Korea, InBody is developing fast in the world market with a global network including local subsidiaries in Japan, US, China and 40 agencies all around the world. In particular, the company is striving to achieve superior competitiveness that will facilitate success in advanced markets around the world, such as those in the United States, Japan, and Europe.

Biospace is not only continuously investing in body composition analysing research, but also developing extra services such as providing a nutrition and exercise guide software ‘Lookin’Body’, a health enhancement system ‘u-town’ and others.